Extrait

The primary objective of this study was to assess the safety and tolerability of a mebendazole 500-mg chewable tablet formulation in a pediatric population (children 2 to 10 years of age, inclusive).

Critère d'inclusion

• Soil-transmitted helminth (STH) infections